Contrave — Medica
weight loss
Initial criteria
- age ≥ 18 years
- patient has engaged in behavioral modification and dietary restriction for at least 3 months
- patient meets ONE of the following: (a) BMI ≥ 30 kg/m2 OR (b) BMI ≥ 27 kg/m2 AND at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease, knee osteoarthritis, asthma, chronic obstructive pulmonary disease, metabolic-dysfunction associated steatotic liver disease/nonalcoholic fatty liver disease, polycystic ovarian syndrome, or coronary artery disease)
- medication used concomitantly with behavioral modification and reduced-calorie diet
Reauthorization criteria
- age ≥ 18 years
- patient met BMI criteria at baseline (≥ 30 kg/m2 OR ≥ 27 kg/m2 with comorbidity)
- patient has lost ≥ 5% of baseline body weight
- medication used concomitantly with behavioral modification and reduced-calorie diet
Approval duration
initial 4 months; reauth 1 year